cost. An alternative diagnostic approach is to artificially increase the number of bacteria, or markers of those bacteria, present in a given sample. One of the advantages of using the polymerase chain reaction to amplify mycobacterial DNA is that the specificity of the method depends on the precise DNA sequence chosen for amplification. This technique has been shown to be successful in detecting mycobacteria, with a greater sensitivity than that of routine smear and culture, in sputum, pleural fluid, cerebrospinal fluid, pericardial fluid, pus, urine, and tissue samples. 5 The sensitivity depends on the number of amplification cycles and can be increased by the amplification of a DNA sequence present in multiple rather than single copies in each genome. de Lassence and colleagues describe such a technique in this issue.6 It allowed the detection of as little as one mycobac teteLuraamee and confirmed a tuberculous cause for the pleural uid, without any loss of specificity, in most of the 15 patients, whose tuberculosis was confirmed by other means. The extreme sensitivity of their technique could, however, be its downfall, as false positive results, presumably due to contamination, are reported, indicating the need for scrupulous laboratory methods and practice.7 The value of the polymerase chain reaction in "dirty" samples, such as sputum, remains to be proved. Although the technique usually requires material from the site of infection, the positive results obtained from blood from patients with tuberculosis who had AIDS suggest that this may not always be necessary.8
Serology and the polymerase chain reaction method may be mutually exclusive or complementary, but further evaluation in prospective studies and direct comparison of the two techniques will be required to determine their respective roles. In future it may be possible to tailor the diagnostic test to particular circumstances. In non-industrialised countries, where most mycobacterial infections are tuberculous, a single monoclonal antibody or DNA sequence specific for M tuberculosis could be used whereas in patients with AIDS, for example, where distinction between types of mycobacterial infection is important, antibodies or DNA sequences with differing specificities will be required.
The potential sensitivity of the polymerase chain reaction method could allow this to replace smear examinations if specificity is maintained, especially in "dirty" samples. In non-industrialised countries, however, the simplicity of the sputum smear and its availability at the point of access to medical care are unlikely to be surpassed by such sophisticated techniques, though they may become a useful addition in smear negative cases. Although the results of both the approaches described are exciting, further work is needed to clarify their specificity and sensitivity in different circumstances and to simplify laboratory procedures. Finally, the practicability of their large scale use requires evaluation.
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